BCN Medical Listed by thegentlemen Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On March 16, 2026, the ransomware group thegentlemen listed BCN Medical on its leak site, stating that internal files had been taken during an attack on the Colombian pharmaceutical distributor. The number of individuals whose information may be involved remains unknown, as does any confirmation that the data has been published or sold. For patients, healthcare providers, and business partners who interact with such distributors, the incident raises the possibility that records tied to medication supply chains could be exposed, though the precise contents and scope are not yet public.

Breaking down the breach

The only confirmed detail is the listing itself. No information has been released on when the intrusion occurred, how many files were taken, or whether any ransom demand was made or met. The reported summary describes the event simply as a ransomware attack in which internal files were allegedly exfiltrated. No further technical indicators, payment records, or statements from BCN Medical have been made available.

Inside thegentlemen

Thegentlemen is a ransomware group that maintains a public leak site where it lists organizations it claims to have compromised. Like similar actors, the group typically exfiltrates data before encrypting systems and then uses the threat of publication to pressure victims. The listing of BCN Medical constitutes the group’s claim; independent verification of the underlying access or the volume of data has not been provided in public reporting.

BCN Medical and its sector

BCN Medical, based in Bogotá, was founded in 1999 and operates as a pharmaceutical distributor of medications, supplements, and medical devices. The company was later acquired by Faes Farma. Organizations in this sector routinely handle procurement records, supplier contracts, inventory data, and correspondence that can include details about shipments to hospitals, pharmacies, and clinics. A compromise in this environment can affect supply-chain continuity even when patient clinical records are not directly involved.

The information in question

The listing refers only to “internal files.” No inventory of file names, categories, or record counts has been disclosed. Pharmaceutical distributors commonly store purchase orders, pricing agreements, regulatory compliance documents, and contact information for healthcare customers. Without a published sample or official notification, the exact nature of the exfiltrated material remains unconfirmed.

What's at stake

Exposed internal files could reveal commercial relationships, pricing structures, or shipment schedules that competitors or other actors might exploit. For individuals named in those records, the main risks are targeted phishing or social-engineering attempts that use the leaked details as context. The organization faces potential regulatory scrutiny in Colombia and operational questions from its customers and parent company, though the scale of any such impact is still unknown.

What to do if you're exposed

Individuals who have done business with BCN Medical or similar distributors should monitor their email and postal addresses for unusual correspondence. Basic steps include enabling multi-factor authentication on any accounts that may share contact details with the company and reviewing bank or insurance statements for unexpected activity. Readers can run a free exposure scan of their email address against known breach data to check whether their information appears in previously published sets.

AICompiled with AI assistance from public sources and published under our editorial standards.